Symposium(9:10 AM - 10:10 AM JST)[D2-A1]Advancing drug development: Comprehensive and optimum approaches to the immunogenicity assessmentChairman:Hiroyuki Shimizu(Mitsubishi Tanabe Pharma Corporation), Hisanori Hara(B2S Life Sciences)OpenClose
Symposium(3:25 PM - 4:55 PM JST)[D2-A2]JSQA Collaboration Session: Issues and Recommendations for Promoting Data Integrity in GLP FacilitiesChairman:Noriyuki Koyama(Otsuka Pharmaceutical Co., Ltd.), Takeshi Okuzono(Sekisui Medical Co., Ltd.)OpenClose
Symposium(5:00 PM - 6:00 PM JST)[D2-A3]Progress in bioanalysis using new technology of mass spectrometryChairman:Yohei Ohashi(Kyorin Pharmaceutical Co., Ltd.), Tsubasa Ibushi(Shimadzu Techno-Research, Inc.)OpenClose
Round Table Discussion(3:25 PM - 6:00 PM JST)[D2-C2]ADA Round Table DiscussionChairman:Hiroyuki Shimizu(Mitsubishi Tanabe Pharma Corporation), Hisanori Hara(B2S Life Sciences)OpenClose